Clarentis Technologies owns the patent rights and Intellectual Property to an innovative technology that manufactures non-toxic, EPA registered solutions that are hospital-grade disinfectant/antimicrobials. The two solutions produced through our proprietary Ultra-Lyte System; Ultra-Lyte & Zero-L…
Clarentis Technologies owns the patent rights and Intellectual Property to an innovative technology that manufactures non-toxic, EPA registered solutions that are hospital-grade disinfectant/antimicrobials. The two solutions produced through our proprietary Ultra-Lyte System; Ultra-Lyte & Zero-Lyte are organic and kill (no adaptation) common bacteria across a broad spectrum of applications, but also eradicate antibiotic resistant strains of the most virulent pathogens found around the globe. Cost effective, we are positioned to address the growing requirements of not only corporations seeking to achieve their eco-friendly and sustainability mandates, but the current and pending federal, state, local and global standards to realize public health guidelines without human, animal and ecological devastation and to seamlessly integrate into everyday protocols and practices.
Team (2)
Sectors Clarentis Technologies serves:
Energy & Utilities
Consumer Services
Distribution
Health Care
Business Services
Life Sciences
Join Axial's Private M&A Platform
Clarentis Technologies connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
